Health Care [ 12/12 ] | Health Care Technology [ 54/74 ]
NASDAQ | Common Stock
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services.
The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights.
It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening.
GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 53.30 M Decreased by -35.96% | -42.29 M Increased by +45.49% | Decreased by -79.33% Increased by +14.89% |
| Jun 30, 23 | 48.71 M Increased by +34.66% | -46.72 M Increased by +45.51% | Decreased by -95.92% Increased by +59.54% |
| Mar 31, 23 | 43.14 M Decreased by -20.03% | -60.99 M Increased by +5.42% | Decreased by -141.38% Decreased by -18.26% |
| Dec 31, 22 | 61.35 M Increased by +6.14% | -308.76 M Decreased by -668.35% | Decreased by -503.28% Decreased by -623.90% |
| Sep 30, 22 | 83.23 M Increased by +92.77% | -77.58 M Decreased by -347.14% | Decreased by -93.21% Decreased by -228.20% |
| Jun 30, 22 | 36.17 M Decreased by -22.82% | -85.74 M Decreased by -89.02% | Decreased by -237.06% Decreased by -144.91% |
| Mar 31, 22 | 53.94 M Decreased by -15.98% | -64.49 M Increased by +66.37% | Decreased by -119.55% Increased by +59.98% |
| Dec 31, 21 | 57.80 M Decreased by -9.63% | -40.19 M Increased by +68.03% | Decreased by -69.52% Increased by +64.62% |